Drug & medication recalls Moderate risk

HydrALAZINE HYDROCHLORIDE INJECTION recalled over temperature-control failures

Recall date
March 8, 2017
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Mckesson Medical Surgical recalls hydrALAZINE HYDROCHLORIDE INJECTION, USP, 20 mg/mL, 1 mL Single Dose Vial, packaged in 25 Vials per carton, Rx only, AP…
Recall number
D-0668-2017
FDA classification
Class II
Brand / firm
Mckesson Medical Surgical
Sold / distributed
Nationwide in the USA

Why it was recalled

Temperature Abuse: Certain pieces of these lots distributed by McKesson Medical Surgical Inc. were inadvertently stored refrigerated rather than the labeled room temperature recommendation.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

hydrALAZINE HYDROCHLORIDE INJECTION, USP, 20 mg/mL, 1 mL Single Dose Vial, packaged in 25 Vials per carton, Rx only, APP Fresenius Kabi USA, LLC, Lake Surich, IL 60047, NDC 63323-614-01, Distributed by McKesson Medical-Surgical, Inc.

Get recall alerts

Free email alert whenever Mckesson Medical Surgical has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Mckesson Medical Surgical